BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 26969735)

  • 1. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
    Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
    Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
    Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
    Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
    Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
    Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus-Specific Regulation of
    Deng M; Liu Z; Chen B; Cai Y; Wan Y; Wang F
    DNA Cell Biol; 2020 Apr; 39(4):572-578. PubMed ID: 32073884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
    Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
    Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria.
    Xiong T; Rohm D; Workman RE; Roundtree L; Novina CD; Timp W; Ostermeier M
    PLoS One; 2018; 13(12):e0209408. PubMed ID: 30562388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
    Bashtrykov P; Rajaram N; Jeltsch A
    Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins.
    Ding L; Schmitt LT; Brux M; Sürün D; Augsburg M; Lansing F; Mircetic J; Theis M; Buchholz F
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35288457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-mediated promoter de/methylation technologies for gene regulation.
    Sung CK; Yim H
    Arch Pharm Res; 2020 Jul; 43(7):705-713. PubMed ID: 32725389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of gene expression by altered promoter methylation using a CRISPR/Cas9-mediated epigenetic editing system.
    Kang JG; Park JS; Ko JH; Kim YS
    Sci Rep; 2019 Aug; 9(1):11960. PubMed ID: 31427598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated gene knockout for DNA methyltransferase Dnmt3a in CHO cells displays enhanced transgenic expression and long-term stability.
    Jia YL; Guo X; Lu JT; Wang XY; Qiu LL; Wang TY
    J Cell Mol Med; 2018 Sep; 22(9):4106-4116. PubMed ID: 29851281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notes on Functional Modules in the Assembly of CRISPR/Cas9-Mediated Epigenetic Modifiers.
    Kondrashov A; Karpova E
    Methods Mol Biol; 2021; 2198():401-428. PubMed ID: 32822047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of DNA methylation of exons on alternative splicing.
    Shayevitch R; Askayo D; Keydar I; Ast G
    RNA; 2018 Oct; 24(10):1351-1362. PubMed ID: 30002084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase.
    Stepper P; Kungulovski G; Jurkowska RZ; Chandra T; Krueger F; Reinhardt R; Reik W; Jeltsch A; Jurkowski TP
    Nucleic Acids Res; 2017 Feb; 45(4):1703-1713. PubMed ID: 27899645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.